GlassScriptPhysician profile
Steve B Skarky
NPI 1225145378
$4,022.23
in general payments reported to CMS, 2019-2025
37 companies · $537 in 2025
The $537 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.91 · 2020: $451 · 2021: $408 · 2022: $101 · 2023: $1,264 · 2024: $1,176 · 2025: $537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,977.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,976.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $613.07 | 2019-2025 | Spravato |
| Otsuka America Pharmaceutical, INC. | $491.23 | 2019-2025 | Rexulti |
| Lundbeck LLC | $401.93 | 2023-2025 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $388.15 | 2020-2024 | Trintellix |
| Abbvie INC. | $256.95 | 2021-2023 | Vraylar |
| Axsome Therapeutics, INC. | $239.63 | 2023-2025 | Auvelity |
| Corium, LLC | $203.50 | 2022-2024 | Azstarys |
| Noven Therapeutics, LLC | $189.99 | 2023-2025 | Xelstrym, Secuado |
| Allergan, INC. | $150.72 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $135.56 | 2023 | Belsomra |
| Teva Pharmaceuticals USA, INC. | $92.05 | 2020-2023 | Austedo Xr |
| Stryker Corporation | $88.60 | 2024 | Aequalis Perform, Blueprint Patient Specific Instrumentation |
| Novo Nordisk INC | $67.14 | 2023-2024 | Rybelsus, Ozempic, Wegovy |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $58.64 | 2024 | Caplyta |
| Paratek Pharmaceuticals, INC. | $50.93 | 2025 | Nuzyra |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $45.00 | 2021 | |
| Alkermes, INC. | $43.77 | 2022-2023 | Lybalvi |
| Adlon Therapeutics L.P. | $41.08 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $40.24 | 2023-2025 | Zilretta, Iovera, Exparel |
| Depuy Synthes Sales INC. | $40.18 | 2025 | Healix Knotless Peek, Truespan Orthocord |
| Lilly USA, LLC | $38.49 | 2023 | Jardiance |
| Vertex Pharmaceuticals Incorporated | $36.49 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $30.50 | 2023 | Breztri |
| Baxter Healthcare | $27.93 | 2025 | Hillrom - Monarch Airway Clearance System |
| Medacta USA, INC. | $26.02 | 2024 | |
| Ermi LLC | $25.25 | 2023 | |
| Corcept Therapeutics | $22.65 | 2025 | Korlym |
| Eisai INC. | $21.43 | 2020 | |
| Esperion Therapeutics, INC. | $19.80 | 2024 | Nexletol |
| Glaxosmithkline, LLC. | $19.22 | 2024 | Trelegy Ellipta, Arexvy |
| Ironshore Pharmaceuticals INC. | $17.75 | 2019 | |
| Vanda Pharmaceuticals INC. | $17.32 | 2024 | Fanapt |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.89 | 2025 | Jardiance |
| Kowa Pharmaceuticals America, INC. | $16.85 | 2023 | Seglentis |
| Shire North American Group INC | $16.24 | 2019 | |
| Pylant Medical | $15.84 | 2023 | |
| Exact Sciences Corporation | $15.20 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve Skarky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.